top of page
gradientForSurfBreak.png

Item List

Cision PR Newsire
Matterworks Announces Updates to its Board of Directors

Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and manufacturing of biologics and gene therapies, today announces updates to its Board of Directors.

"Expansion of our Board of Directors is particularly timely as we approach the beta release in early 2023 and commercial launch in the summer of 2023 of Pyxis™, our next-generation machine learning software platform,'' said Mimoun Cadosch Delmar, Founder & CEO of Matterworks.

Recent Posts

Portfolio Company

Carlsmed.png

Top 20 UK and EU Artificial Intelligence Startups To Look Out For in 2024 ...

TechRound

Portfolio Company

Carlsmed.png

Skin Analytics looks to remap patient pathways for cancer diagnoses ...

Digital Health

General News

Carlsmed.png

AdvaMed Praises Administration’s “Women’s Health Research” Initiative ...

AdvaMed

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page